Equities

SSY Group Ltd

SSY Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)3.81
  • Today's Change-0.03 / -0.78%
  • Shares traded8.46m
  • 1 Year change-12.21%
  • Beta0.5824
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,6161,7141,700
Total Receivables, Net2,3212,2482,216
Total Inventory1,114843870
Prepaid expenses3.235.1513
Other current assets, total697585
Total current assets5,1244,8844,884
Property, plant & equipment, net5,0534,5174,382
Goodwill, net254257269
Intangibles, net904782638
Long term investments588498504
Note receivable - long term------
Other long term assets------
Total assets11,96610,96710,709
LIABILITIES
Accounts payable408361402
Accrued expenses799690
Notes payable/short-term debt000
Current portion long-term debt/capital leases1,4231,6481,417
Other current liabilities, total611573485
Total current liabilities2,5212,6782,394
Total long term debt1,9511,5621,691
Total debt3,3743,2093,108
Deferred income tax212121
Minority interest336332274
Other liabilities, total204160110
Total liabilities5,0344,7534,490
SHAREHOLDERS EQUITY
Common stock666667
Additional paid-in capital9.4633113
Retained earnings (accumulated deficit)7,3886,5245,789
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(531)(409)250
Total equity6,9336,2146,219
Total liabilities & shareholders' equity11,96610,96710,709
Total common shares outstanding2,9692,9742,997
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.